http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5981170-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_725ba6bcb224fcbc2d59c859fc4556e4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-21
filingDate 1988-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_060e1a566285983630147c8852d8a54d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7fd96ada00e7fbdef65dca315b3d8c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f715da5a1347d27d0b4b42c40910288b
publicationDate 1999-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5981170-A
titleOfInvention Peptides, artificial antigens and immunoassay kits
abstract PCT No. PCT/SE88/00570 Sec. 371 Date Jun. 22, 1990 Sec. 102(e) Date Jun. 22, 1990 PCT Filed Oct. 27, 1988 PCT Pub. No. WO89/03844 PCT Pub. Date May 5, 1989An artificial peptide having an amino acid sequence which corresponds to a naturally occurring amino acid sequence of a HIV comprising an epitope and which further has two cysteine residues located on each side of said epitope, and further having a sulphur bridge between said two cysteine residues, which has been formed by a chemical oxidation step, is described. Furthermore, an artificial antigen which reacts with antibodies induced by a HIV is described. Said antigen mainly consists of an artificial peptide according to the invention. Additionally, a method of detecting antibodies induced by a HIV in a sample of body fluid, wherein said sample is subjected to an immunoassay, especially ELISA, and wherein an artificial antigen according to the invention is used as a diagnostic antigen, is described. A diagnostic immunoassay kit for said method is also described. Finally, a vaccine composition comprising, as an immunizing component, at least one antigen according to the invention, is described.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007077253-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012170765-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807634-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275826-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2848937-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7786076-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7615530-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3069730-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3072901-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2586461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2568289-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7723294-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7781399-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2873423-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3187585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008241228-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010247633-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2679596-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028410-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010028423-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807633-B2
priorityDate 1987-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8706005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5001049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0247557-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4812556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4957737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0219106-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0214709-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4629783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4879212-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8606414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4735896-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12209349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226443003
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129647280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7519
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227552018
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226473709
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129369570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394012
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226426932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID522325
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2734295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413191

Total number of triples: 80.